Boston Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-15,515
| Closed | -$278K | – | 669 |
|
|
2017
Q3 | $278K | Sell |
15,515
-335
| -2% | -$6K | 0.01% | 581 |
|
|
2017
Q2 | $258K | Sell |
15,850
-20,230
| -56% | -$329K | 0.01% | 599 |
|
|
2017
Q1 | $505K | Sell |
36,080
-2,785
| -7% | -$39K | 0.01% | 467 |
|
|
2016
Q4 | $620K | Buy |
38,865
+6,195
| +19% | +$98.8K | 0.01% | 437 |
|
|
2016
Q3 | $544K | Sell |
32,670
-3,520
| -10% | -$58.6K | 0.01% | 488 |
|
|
2016
Q2 | $405K | Buy |
36,190
+245
| +0.7% | +$2.74K | 0.01% | 529 |
|
|
2016
Q1 | $301K | Buy |
35,945
+380
| +1% | +$3.18K | 0.01% | 587 |
|
|
2015
Q4 | $331K | Hold |
35,565
| – | – | 0.01% | 556 |
|
|
2015
Q3 | $401K | Buy |
+35,565
| New | +$401K | 0.02% | 586 |
|